Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Net sales
Net sales	$ 895.4	$ 858.1
Cost of sales
Total cost of sales	686.8	648.8
Gross profit	208.6	209.3
Selling and administrative expense	161.6	183.8
Research, development and engineering expense	24.2	26.4
(Gain) loss on sale of assets, net	(1.0)	0.3
Impairment of assets	0.0	0.9
Total operating expense	184.8	211.4
Operating profit (loss)	23.8	(2.1)
Other income (expense)
Interest income	4.2	1.7
Interest expense	(43.6)	(81.9)
Foreign exchange gain (loss), net	0.4	(10.6)
Miscellaneous gain, net	1.0	2.6
Loss before taxes	(14.2)	(90.3)
Income tax (benefit) expense	(3.1)	21.1
Equity in earnings (loss) of unconsolidated subsidiaries, net	(2.9)	(0.1)
Net loss	(14.0)	(111.5)
Net (loss) income attributable to noncontrolling interests	0.6	(0.4)
Net loss attributable to Diebold Nixdorf, Incorporated	$ (14.6)	$ (111.1)
Basic weighted-average shares outstanding (in shares)	37.6	79.3
Diluted weighted-average shares outstanding (in shares)	37.6	79.3
Net loss attributable to Diebold Nixdorf, Incorporated
Basic loss per share (in dollars per share)	$ (0.39)	$ (1.40)
Diluted loss per share (in dollars per share)	$ (0.39)	$ (1.40)
Services
Net sales
Net sales	$ 524.8	$ 516.4
Cost of sales
Total cost of sales	408.7	363.0
Products
Net sales
Net sales	370.6	341.7
Cost of sales
Total cost of sales	$ 278.1	$ 285.8